• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Okada Hirokazu  岡田 浩和

ORCIDConnect your ORCID iD *help
… Alternative Names

okada hirokazu  岡田 浩和

Less
Researcher Number 60911823
Affiliation (Current) 2025: 独立行政法人国立病院機構(京都医療センター臨床研究センター), 臨床研究企画運営部, 研究員
Affiliation (based on the past Project Information) *help 2023: 独立行政法人国立病院機構(京都医療センター臨床研究センター), 臨床研究企画運営部, 研究員
2021 – 2022: 京都大学, 医学研究科, 医員
Review Section/Research Field
Principal Investigator
Basic Section 50020:Tumor diagnostics and therapeutics-related / 0901:Oncology and related fields
Keywords
Principal Investigator
膵がん / がんワクチン / 免疫学 / 腫瘍学
  • Research Projects

    (2 results)
  • Research Products

    (2 results)
  • Co-Researchers

    (1 People)
  •  膵がんにおける術前in situワクチン免疫複合療法の開発Principal Investigator

    • Principal Investigator
      岡田 浩和
    • Project Period (FY)
      2023 – 2025
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 50020:Tumor diagnostics and therapeutics-related
    • Research Institution
      Department of Clinical Research, National Hospital Organization Kyoto Medical Center
  •  Neoadjuvant in situ vaccination for pancreatic cancerPrincipal Investigator

    • Principal Investigator
      okada hirokazu
    • Project Period (FY)
      2021 – 2022
    • Research Category
      Grant-in-Aid for Research Activity Start-up
    • Review Section
      0901:Oncology and related fields
    • Research Institution
      Kyoto University

All 2023 2022

All Journal Article Presentation

  • [Journal Article] In situ vaccination using unique TLR9 ligand K3-SPG induces long-lasting systemic immune response and synergizes with systemic and local immunotherapy2022

    • Author(s)
      Okada H, Takahashi K, Yaku H, Kobiyama K, Iwaisako K, Zhao X, Shiokawa M, Uza N, Kodama Y, Ishii KJ, Seno H.
    • Journal Title

      Sci Rep.

      Volume: 12 Issue: 1 Pages: 2132-2132

    • DOI

      10.1038/s41598-022-05702-0

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-20H03659, KAKENHI-PROJECT-20K08996, KAKENHI-PROJECT-21K20802, KAKENHI-PROJECT-20K08329
  • [Presentation] In situ vaccine combining TLR9 nanoligand K3-SPG and nearinfrared photoimmunotherapy evokes potent antitumor immunity2023

    • Author(s)
      夜久大晃、高橋健、岡田浩和ら
    • Organizer
      第82回日本癌学会学術総会
    • Data Source
      KAKENHI-PROJECT-23K14647
  • 1.  妹尾 浩
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi